Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2023-02-14 Interim / Quarterly Rep…
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors of Ajooni Biotech Limited regarding the approval of the un-audited financial results for the quarter ended December 31, 2022. It includes financial tables with income, expenses, profit, and assets and liabilities statements. The document references Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results disclosures. The presence of detailed financial data for the quarter, including profit and loss and balance sheet items, indicates this is a quarterly financial report rather than a brief earnings release or a simple announcement. The document is about un-audited quarterly financial results, which fits the definition of an Interim / Quarterly Report (IR). It is not a full annual report (10-K), nor is it a short announcement or certification. Therefore, the correct classification is IR (Interim / Quarterly Report).
2023-02-14 English
Updates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to the National Stock Exchange of India regarding an update on an international grant application submitted by Ajooni Biotech Limited. It describes the nature of the grant, the collaborating entities, and the intended use and benefits of the grant. There are no financial statements, earnings data, or detailed financial analysis present. The document is relatively short (4045 characters) and serves as an announcement of a corporate development rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories.
2023-02-13 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about an upcoming Board Meeting scheduled for February 14, 2023. The agenda includes consideration and approval of unaudited financial results for the quarter ended December 31, 2022, along with a limited review report by the statutory auditor. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of a meeting where financial results will be discussed and approved, not the financial report itself. The document length is only 1507 characters, which is quite short and consistent with a meeting notice. Therefore, this document fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification to the exchange about the board meeting and agenda.
2023-02-06 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate submitted pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended 31 December 2022. It is a certificate issued by the Registrar and Transfer Agent (RTA) confirming dematerialisation of securities and related compliance. The document does not contain financial statements, management discussion, or detailed financial data. It is a regulatory compliance certificate rather than a financial report or announcement of voting results, capital changes, or management changes. The document length is short (2823 characters) and primarily serves as a confirmation certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2023-01-11 English
Updates
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate submitted to the National Stock Exchange of India as per Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. It confirms the dematerialisation of securities for the quarter ended 31 December 2022. The document is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion but is a formal regulatory filing to confirm compliance with securities regulations. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2823 characters), and it is a certificate, not a report or announcement of a report, so it is not a report publication announcement (RPA).
2023-01-10 English
Copy of Newspaper Publication
Capital/Financing Update Classification · 95% confidence The document contains a submission to the National Stock Exchange of India regarding the filing of a post-issue advertisement related to the basis of allotment pursuant to a Rights Issue of Equity Shares by Ajooni Biotech Limited. This is a formal announcement about the completion and publication of a specific corporate action (Rights Issue allotment advertisement). The document also includes excerpts from a business newspaper discussing financial and market information, but the primary filing is the post-issue advertisement submission to the stock exchange. The document is not a full financial report, earnings release, or management discussion, but rather an official announcement related to a capital raising event. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content support this classification with high confidence.
2023-01-02 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.